SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of INVO Bioscience, Inc. (Nasdaq – INVO)

BALA CYNWYD – October 23, 2023 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of INVO Bioscience, Inc. (“INVO” or the “Company”) (Nasdaq – INVO) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the merger of the Company with NAYA Biosciences Inc. (“NAYA”), in an all-stock transaction. Under the terms of the agreement, NAYA shareholders will receive 7.3333 shares of INVO for each share of NAYA held. At closing, INVO and NAYA shareholders will own approximately 12% and 88%, respectively, of the combined company.

The investigation concerns whether the INVO Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.

If you own shares of INVO stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.